![Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE) - UCLA-Olive View Internal Medicine Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE) - UCLA-Olive View Internal Medicine](https://www.oliveviewim.org/wp-content/uploads/2020/07/rave-nejm.png)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE) - UCLA-Olive View Internal Medicine
![Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatment | Annals of the Rheumatic Diseases Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatment | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/60/5/538/F1.large.jpg?download=true)
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatment | Annals of the Rheumatic Diseases
![Idiopathic mixed small and medium vessel cutaneous vasculitis: A case report | The Foot and Ankle Online Journal Idiopathic mixed small and medium vessel cutaneous vasculitis: A case report | The Foot and Ankle Online Journal](http://faoj.org/wp-content/uploads/2014/03/figure-2.jpg)